Federal officials plan to send warning letters to companies marketing products with 7-OH, part of effort to fight America's ...

Supporters argue it is a safer, natural alternative to opioids. But critics and regulators warn about the risks of dependence ...

The FDA says synthetic, concentrated 7-hydroxymitragyine, a potent metabolite of kratom, is an opioid and should be ...

OH is not regulated, and so products like chewable tablets or gummies can be legally sold at places like vape shops or gas stations.

A new opioid threat you probably haven't heard about is targeting kids. Products containing 7-OH are currently being sold ...

FDA officials also called for federal scheduling of the substance due to its risks, distinguishing it from the natural kratom plant.

High-mitragynine products have been tied to more than 200. Regardless, we believe 7-OH should be regulated with age limits, dosage caps, labeling and third-party testing. It's just common sense.

The Mitragynine space is poised for a similar inflection point. Clear, reasonable guidelines will not only provide consumer safety—they'll also enable retailers, distributors, and investors to ...

High-mitragynine products have been tied to more than 200. Regardless, we believe 7-OH should be regulated with age limits, dosage caps, labeling and third-party testing. It’s just common sense.